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Assessment of an incentivised scheme to provide annual 
health checks in primary care for adults with intellectual 
disability: a longitudinal cohort study
Marta Buszewicz, Catherine Welch, Laura Horsfall, Irwin Nazareth, David Osborn, Angela Hassiotis, Gyles Glover, Umesh Chauhan, 
Matthew Hoghton, Sally-Ann Cooper, Gwen Moulster, Rosalyn Hithersay, Rachael Hunter, Pauline Heslop, Ken Courtenay, André Strydom
Summary
Background People with intellectual disabilities (ID) have many comorbidities but experience inequities in access to 
health care. National Health Service England uses an opt-in incentive scheme to encourage annual health checks of 
patients with ID in primary care. We investigated whether the ﬁ rst 3 years of the programme had improved health 
care of people with ID.
Methods We did a longitudinal cohort study that used data from The Health Improvement Network primary care 
database. We did multivariate logistic regression to assess associations between various characteristics and whether 
or not practices had opted in to the incentivised scheme.
Findings We assessed data for 8692 patients from 222 incentivised practices and those for 918 patients in 48 non-
incentivised practices. More blood tests (eg, total cholesterol, odds ratio [OR] 1·88, 95% CI 1·47–2·41, p<0·0001) 
general health measurements (eg, smoking status, 6·0, 4·10–8·79, p<0·0001), speciﬁ c health assessments (eg, 
hearing, 24·0, 11·5–49·9, p<0·0001), and medication reviews (2·23, 1·68–2·97, p<0·0001) were done in incentivised 
than in non-incentivised practices, and more health action plans (6·15, 1·41–26·9, p=0·0156) and secondary care 
referrals (1·47, 1·05–2·05, p=0·0256) were made. Identiﬁ cation rates were higher in incentivised practices for thyroid 
disorder (OR 2·72, 95% CI 1·09–6·81, p=0·0323), gastrointestinal disorders (1·94, 1·03–3·65, p=0·0390), and obesity 
(2·49, 1·76–3·53, p<0·0001).
Interpretation Targeted annual health checks for people with ID in primary care could reduce health inequities.
Funding National Institute for Health Research.
Copyright © Buszewicz et al. Open Access article distributed under the term of CC BY.
Introduction
Intellectual disability (ID), also known as learning 
disability in the UK, is deﬁ ned as substantial impairments 
of intellectual function and social or adaptive functioning 
present from childhood.1 People with ID have a diﬀ erent 
pattern of health needs from the general population, 
with increased rates of comorbidities, including physical 
disabilities, sensory impairments, mental health 
problems, epilepsy, and disorders of the respiratory, 
gastrointestinal, and endocrine systems.2,3 Accordingly, 
patients with ID are at increased risk of death from 
preventable or treatable illnesses,4–6 and among those 
with moderate or profound ID, all-cause mortality is 
almost three times higher than in the general population.7 
Despite increased health needs, these patients face 
notable health inequities, including barriers to primary 
care.6,8 Identiﬁ ed concerns include lower than expected 
rates for primary care consultations and uptake of 
screening activities and poor access to health-promotion 
activities.9
Whether any routine general health checks for middle-
aged patients in primary care are eﬀ ective is debated.10 
However, identiﬁ cation and management of health 
issues in other populations with complex needs, such as 
the frail elderly, gives some support for the eﬀ ectiveness 
of comprehensive health assessments (anticipatory 
care).11 The ID population is particularly disadvantaged, 
with many inequalities in terms of provision of physical 
and mental health care and limited access to health 
professionals. Small-scale studies of primary care health 
checks have reported increases in health-promotion 
activities and management of long-term disorders that 
have led to improved identiﬁ cation of health needs.12–14 
These steps are crucial to improving health outcomes.
National Health Service (NHS) Wales introduced the 
ﬁ rst national primary care ID health check in 2006, 
followed by NHS England in 2008–09. The English 
scheme is an incentivised directed enhanced service 
called the LD-DES,15 and is optional at practice level. 
Primary care teams are remunerated for undergoing 
appropriate training and completing health checks on 
eligible patients. A framework with local guidance for the 
delivery of primary care health checks is provided by 
NHS England. Although training requirements for the 
delivery of checks are not fully standardised, the Royal 
College of General Practitioners have produced 
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guidelines for primary care physicians and their staﬀ .16 
No assessment of clinical outcomes after the rollout of 
this national scheme has yet been reported.
We aimed to objectively assess the eﬀ ects of the ﬁ rst 
3 years of the NHS England LD-DES scheme for ID. We 
compared the number of health checks attended, health 
assessments and investigations done, and diagnoses of 
common health conditions recorded between general 
practices that had (incentivised) and had not (non-
incentivised) opted in to the scheme. We hypothesised 
that these activities would be more frequent in practices 
opting into the LD-DES.
Methods
Data source
We did a longitudinal cohort study that used data from The 
Health Improvement Network database (THIN), which is 
a large, longitudinal, clinical, primary-care database widely 
used in epidemiological research. Data for THIN are 
collected by Cegedim Strategic Data, London, UK, from 
general practices that have opted in to the data recording 
scheme,17 by use of Vision practice management software. 
Medical events are coded according to the hierarchical 
Read coding system18 and prescriptions are classiﬁ ed 
according to chapters in the British National Formulary and 
coded with encrypted identiﬁ cation codes from the UK 
Prescription Pricing Authority.19
THIN data are representative of the entire UK 
population.20 All data collected are anonymised at source, 
exported from general practice systems, and are continually 
updated. The dataset contains data from over 10 million 
patients registered with 578 practices since 1988,21 and 
provides details of consultations with physicians and 
nurses, including symptoms, diagnoses, interventions, 
laboratory test results, and secondary care referrals, 
electronically recorded as Read codes.17 All patients’ 
prescriptions, characteristics, lifestyle factors (height, 
weight, and smoking status), and Townsend neighbourhood 
deprivation scores (based on patients’ electoral wards from 
the 2001 Population Census)22 are recorded. Recording of 
consultation and prescription details is similar to that for 
national consultation and prescription statistics.23
Cegedim Strategic Data obtained overall ethical approval 
from the South-East Multicentre Research Ethics 
Committee for provision of the data and we obtained local 
ethics approval for the study protocol.
Study population
English practices were included if, before Jan 1, 2009, the 
average annual recording rates were at least one medical 
record, one additional health data record, and two 
prescription records per patient per year across the whole 
practice population,23,24 and practice mortality recording 
rates were similar to general UK population mortality 
after accounting for the distributions of age and sex.23,25 
We used this date as the cutoﬀ  because the LD-DES was 
introduced in England in 2008–09.
The Townsend deprivation scores were based on the 
2001 census and linked to patients’ records via postcodes, 
which meant that patients living in accommodation built 
after 2001 did not have Townsend scores. We excluded 
practices with Townsend score quintiles recorded for less 
than 80% of patients to ensure that available scores were 
representative of the whole practice.
Figure: Trial proﬁ le
THIN=The Health Improvement Network.
411 general practices in England 
391 practices eligible 
48 non-incentivised
practices assessed 
222 incentivised
practices assessed 
20 practices excluded (<80% of patients 
had Townsend scores recorded)
121 practices excluded 
15 left THIN before 2001
1 below computer use threshold
105 >0 but <0·2 health checks
per ID patient
Incentivised practice Non-incentivised practice
Number of practices 222 48
Number of active patients 1 685 430 334 250
Number of patients with QOF-ID code 8692 918
Mean (95% CI) follow-up time for patients with 
QOF-ID code (years)
2·6 (2·6–2·7) 2·5 (2·5–2·6)
Strategic health authority*
London 911 (10·5%) 29 (3·2%)
East Midlands 420 (4·8%) 108 (11·8%)
East of England 784 (9·0%) 59 (6·4%)
West Midlands 662 (7·6%) 134 (14·6%)
North East 460 (5·3%) 50 (5·5%)
North West 1314 (15·1%) 98 (10·7%)
Yorkshire and Humberside 298 (3·4%) 75 (8·2%)
South Central 1265 (14·6%) 167 (18·2%)
South East Coast 592 (6·8%) 178 (19·4%)
South West 1986 (22·9%) 20 (2·2%)
Sex
Male 4943 (56·9%) 522 (56·9%)
Female 3749 (43·1%) 396 (43·1%)
Age group (years)
18–29 2433 (28·0%) 229 (25·0%)
30–39 1677 (19·3%) 180 (19·6%)
40–49 2008 (23·1%) 216 (23·5%)
50–59 1340 (15·4%) 150 (16·3%)
60–69 797 (9·2%) 94 (10·2%)
70–100 437 (5·0%) 49 (5·3%)
(Table 1 continues on next page)
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Eligible patients had known ID identiﬁ ed with speciﬁ c 
Read codes used to include them in the practice quality 
and outcomes framework (QOF) register, which is an 
electronic system used to record the care provided for 
selected groups of patients.26 Eligible patients were also 
aged at least 18 years and had been permanently 
registered with the practice by Jan 1, 2009 with their date 
of birth, sex, and Townsend deprivation quintile recorded. 
Follow-up started from Jan 1, 2009, until the earliest of 
death, transfer of the patient out of the practice, the 
practice ceasing to contribute THIN data, or Dec 31, 2011 
(the latest complete year of available THIN data at the 
time of analysis).
Deﬁ nition of practices
Incentivised practices were identiﬁ ed through speciﬁ c 
Read codes used by the practices to claim payment for 
ID health checks, termed QOF-ID codes in this Article. 
Because THIN data are anonymised at the patient and 
practice levels, we needed to ﬁ nd a way of distinguishing 
between practices that had opted in to the incentivised 
scheme and those that had not. The distribution of 
health checks per patient for each practice indicated that 
practices with rates higher than 0·2 checks per patient 
with ID were likely to have opted in to the LD-DES 
scheme and, therefore, we used this cutoﬀ  to identify 
practices oﬀ ering annual ID checks. We compared these 
practices with those that had no health checks recorded 
and which were assumed to have not opted in to the 
incentivisation scheme. Practices with more than 0 but 
fewer than 0·2 health checks per patient with ID were 
excluded from the analysis to reduce potential bias by 
mistakenly including practices that had not opted in to 
the scheme in the incentivised group (ﬁ gure).
Identiﬁ cation of patients excluded from the ID health 
check scheme
When English general practices opt in to the incentivised 
scheme, they are provided with a list of adults known by 
local authorities to have a diagnosis of an ID to align with 
the practice ID register.26 Social-care providers (UK local 
authorities) apply speciﬁ c criteria for provision of 
services, and if ID patients do not meet local thresholds 
they might not be included in the local authority register 
and the likelihood of being considered eligible for health 
checks might be lessened.
Additionally, general practices might under-register 
patients with ID, because the QOF-ID codes do not 
include speciﬁ c conditions. For example, a person with 
Down’s syndrome assigned a Read code for the genetic 
condition might not necessarily also be assigned one for 
ID. To address a concern that potentially eligible patients 
might be excluded from the incentivised health checks, 
we used code lists developed for another project27 to 
identify those with genetic and other conditions known 
to be associated with ID (eg Down’s syndrome) or with 
disorders where the majority of patients (more than 
60%) have ID. For this reason, the International 
Classiﬁ cation of Diseases 10th edition diagnosis of 
childhood autism was included, but Asperger’s 
syndrome and cerebral palsy were excluded (a full list of 
disorders is provided in the appendix). We investigated 
how many people on these lists had been given QOF-ID 
codes in the practices being studied and compared them 
with those not given QOF-ID codes in terms of their 
recorded health needs and the likelihood of them 
receiving ID health checks.
See Online for appendix
Incentivised practice Non-incentivised practice
(Continued from previous page)
Townsend deprivation score quintile
1 (least) 1595 (18·4%) 189 (20·6%)
2 1618 (18·6%) 184 (20·0%)
3 1866 (21·5%) 153 (16·7%)
4 1994 (22·9%) 192 (20·9%)
5 (most) 1619 (18·6%) 200 (21·8%)
Carer type before 2009
No carer speciﬁ ed 8085 (93·0%) 854 (93·0%)
Carer (type unspeciﬁ ed) 607 (7·0%) 64 (7·0%)
Carer (informal) 0 0
BMI (kg/m2)†
Mean (95% CI) 29·0 (28·7–29·2) 29·3 (28·6–30·0)
Median (IQR) 28·2 (23·5–33·4) 28·7 (24·1–33·5)
Missing data 4870 (56·0%) 517 (56·3%)
Systolic blood pressure (mm Hg)†
Mean (95% CI) 125·2 (124·7–125·6) 126·1 (124·8–127·4)
Median (IQR) 124·0 (114·0–135·5) 125·0 (115·0–136·0)
Missing data 4062 (46·7%) 411 (44·8%)
Total cholesterol (mmol/L)†
Mean (95% CI) 4·99 (4·94–5·04) 5·17 (5·02–5·32)
Median (IQR) 4·9 (4·2–5·7) 5·1 (4·3–5·8)
Missing data 6731 (77·4%) 708 (77·1%)
HbA1c (%)† 
Mean (95% CI) 7·14 (7·00–7·28) 7·01 (6·58–7·43)
Median (IQR) 6·7 (5·8–8·3) 6·5 (5·8–8·0)
Missing data 8084 (93·0%) 854 (93·0%)
Comorbidity before 2009
Epilepsy 2784 (32·0%) 303 (33·0%)
Diabetes 537 (6·2%) 63 (6·9%)
Thyroid disorder 733 (8·4%) 75 (8·2%)
Gastrointestinal disorders 1060 (12·2%) 147 (16·0%)
Constipation 1158 (13·3%) 112 (12·2%)
Underweight (BMI <18·5 kg/m²) 726 (8·4%) 80 (8·7%)
Obese (BMI >30·0 kg/m²) 2384 (27·4%) 254 (27·7%)
Asthma or COPD 2011 (23·1%) 190 (20·7%)
Hypertension 1524 (17·5%) 162 (17·7%)
Depression 2974 (34·2%) 303 (33·0%)
QOF=practice quality and outcomes framework. ID=intellectual disability. BMI=body-mass index. HbA1c=glycated 
haemoglobin. COPD=chronic obstructive pulmonary disease. *Previously implemented directives and ﬁ scal policy for 
regions set by the national Department of Health. †Summary of all measurements in 2007 and 2008.
Table 1: Baseline characteristics of patients with ID in directed enhanced service incentivised and 
non-incentivised practices
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Incentivised practices 
(n=4645)*
Non-incentivised 
practices (n=611)*
Absolute risk diﬀ erence 
(95% CI)
Odds ratio (95% CI)† p value
Blood tests
Blood glucose
Prevalence 2305 (49·6%) 272 (44·5%) 5·1% (0·9 to 9·3) 1·24 (0·94 to 1·64)‡ 0·1238
Records per patient 0 (0–2) 0 (0–1) ·· ··
HbA1c
Prevalence 576 (12·4%) 74 (12·1%) 0·3% (–2·7 to 2·8) 1·00 (0·75 to 1·35)‡ 0·9782
Records per patient 0 (0–0) 0 (0–0) ·· ··
Haemoglobin
Prevalence 3096 (66·7%) 343 (56·1%) 10·6% (6·4 to 14·7) 1·50 (1·14 to 1·96)‡ 0·0034
Records per patient 1 (0–3) 1 (0–2) ·· ··
Thyroid function
Prevalence 492 (10·6%) 50 (8·2%) 2·4% (–0·2 to 4·5) 1·62 (0·69 to 3·81)‡ 0·2655
Records per patient 0 (0–0) 0 (0–0) ·· ··
Total cholesterol
Prevalence 2412 (51·9%) 234 (38·3%) 13·6% (9·5 to 17·7) 1·88 (1·47 to 2·41)‡ <0·0001
Records per patient 0 (0–2) 0 (0–1) ·· ··
General health status
Height
Prevalence 3183 (68·5%) 209 (34·2%) 34·3% (30·2 to 38·2) 4·06 (2·88 to 5·71)‡ <0·0001
Records per patient 1 (0–2) 0 (0–1) ·· ··
Weight
Prevalence 4365 (94·0%) 383 (62·7%) 31·3% (27·5 to 35·2) 8·75 (5·63 to 13·59)‡ <0·0001
Records per patient 2 (1–4) 1 (0–3) ·· ··
Blood pressure
Prevalence 4428 (95·3%) 436 (71·4%) 23·9% (20·5 to 27·7) 8·67 (6·14 to 12·23)§ <0·0001
Records per patient 3 (2–5) 2  0–4) ·· ··
Smoking status
Prevalence 4355 (93·8%) 450 (73·7%) 20·1% (16·7 to 23·8) 6·00 (4·10 to 8·79) ¶ <0·0001
Records per patient 2 (1–3) 1 (0–2) ·· ··
Alcohol consumption
Prevalence 4227 (91·0%) 283 (46·3%) 44·7% (40·6 to 48·7) 14·12 (9·00 to 22·15)‡ <0·0001
Records per patient 2 (1–3) 0 (0–1) ·· ··
Assessments
Hearing
Prevalence 3265 (70·3%) 63 (10·3%) 60·0% (57·0 to 62·5) 23·98 (11·53 to 49·87)‡ <0·0001
Records per patient 1 (0–2) 0 (0–0) ·· ··
Sight
Prevalence 2049 (44·1%) 40 (6·6%) 37·5% (34·9% to 39·8) 12·89 (4·48 to 37·1)‡ <0·0001
Records per patient 0 (0–1) 0 (0–0) ·· ··
Behaviour
Prevalence 2584 (55·6%) 67 (11·0%) 44·6% (41·6 to 47·3) 11·45 (5·33 to 24·57)‡ <0·0001
Records per patient 1 (0–2) 0 (0–0) ·· ··
Oral health
Prevalence 2516 (54·2%) 43 (7·0%) 47·2% (44·4 to 49·4) 15·66 (5·43 to 45·19)§ <0·0001
Records per patient 1 (0–2) 0 (0–0) ·· ··
Mobility
Prevalence 2180 (46·9%) 45 (7·4%) 39·5% (36·8 to 41·9) 12·96 (4·49 to 37·37)‡ <0·0001
Records per patient 0 (0–1) 0 (0–0) ·· ··
Medication review
Prevalence 3887 (83·7%) 423 (69·2%) 14·5% (10·8 to 18·4) 2·23 (1·68 to 2·97)‡ <0·0001
Records per patient 4 (2–6) 3 (0–5) ·· ··
(Table 2 continues on next page)
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Statistical analysis
First, we did a logistic regression analysis to investigate 
the association between practice-level characteristics 
(number of patients in each practice, proportion of men, 
patients older than 60 years, patients within the most 
deprived Townsend deprivation score quintile, patients 
with ID, and former strategic health authority) and opting 
into the incentivised scheme for all active patients, 
mutually adjusted for confounding to reduce potential 
bias. Next, we did an assessment limited to patients with 
3 complete years of data, from 2009 to 2011. From the 
incentivised practices, we included patients with at least 
one health check recorded during these 3 years, and 
compared the recording of health assessments completed, 
interventions oﬀ ered, and newly identiﬁ ed common 
health conditions with those in non-incentivised 
practices. We did a logistic regression analysis with each 
of these features as a predictor to investigate their 
association with practices opting into LD-DES, with use 
of robust SEs to allow for clustering within practices and 
adjustment for confounding to reduce potential bias.  We 
initially ﬁ tted logistic regression models adjusted for age 
(years) in 2009, sex, strategic health authority, and 
Townsend deprivation score quintile, and used backwards 
elimination to eliminate strategic health authority, 
Townsend deprivation score quintile, or both, if these 
proved to be non-signiﬁ cant (p<0∙050), because 
associations might also diﬀ er by these two features. 
In eligible incentivised practices, we identiﬁ ed ID 
patients where a Read code indicated they had been 
invited to attend a health check, and separated them 
into groups of attendees (health check Read code 
recorded) or non-attendees (no health check Read codes 
recorded or Read codes indicated they did not attend a 
check). We did a multivariate logistic regression 
analysis, mutually adjusted to reduce potential bias, to 
test the association between attending a health check 
and strategic health authority, sex, age, Townsend 
deprivation quintile, carer type, and comorbidity. We 
excluded health indicators from the regression analysis 
because of missing data. 
We compared patients who had identiﬁ ed disorders 
that are associated with ID but without a recorded QOF-
ID code and patients with relevant QOF-ID codes, in 
Incentivised practices Non-incentivised 
practices
Absolute risk diﬀ erence 
(95% CI)
Odds ratio (95% CI)* p value
Epilepsy 144 of 3030 (4·8%) 22 of 419 (5·3%) –0·5% (–3·2 to 1·4) 0·90 (0·54 to 1·50)† 0·6865
Diabetes 140 of 4356 (3·2%) 23 of 568 (4·1%) –0·9% (–2·9 to 0·6) 0·91 (0·57 to 1·47)‡ 0·7119
Thyroid disorder 101 of 4214 (2·4%) 5 of 561 (0·9%) 1·5% (0·3 to 2·2) 2·72 (1·09 to 6·81)† 0·0323
Gastrointestinal disorders 294 of 4080 (7·2%) 22 of 520 (4·2%) 3·0% (0·8 to 4·6) 1·94 (1·03 to 3·65)§ 0·0390
Constipation 198 of 3962 (5·0%) 11 of 547 (2·0%) 3·0% (1·3 to 4·1) 2·59 (1·29 to 5·22)† 0·0080
Underweight (BMI <18·5 kg/m²) 118 of 4263 (2·8%) 8 of 558 (1·4%) 1·4% (–0·1 to 2·2) 1·96 (0·94 to 4·07)† 0·0721
Obese (BMI >30·0 kg/m²) 565 of 3248 (17·4%) 34 of 444 (7·7%) 9·7% (6·6 to 12·3) 2·49 (1·76 to 3·53)‡ <0·0001
Asthma or COPD 185 of 3632 (5·1%) 24 of 489 (4·9%) 0·2% (–2·2 to 2·0) 1·03 (0·69 to 1·53)† 0·8798
Hypertension 256 of 3854 (6·6%) 30 of 510 (5·9%) 0·7% (–1·7 to 2·7) 1·16 (0·78 to 1·73)‡ 0·4521
Depression 343 of 3104 (11·1%) 42 of 409 (10·3%) 0·8% (–2·7 to 3·6) 1·07 (0·73 to 1·55)¶ 0·7375
BMI=body-mass index. COPD=chronic obstructive pulmonary disease. *Backwards elimination used to ﬁ nd signiﬁ cant (p<0·1) covariates. †Adjusted for age and sex. 
‡Adjusted for age, sex, and strategic health authority. §Adjusted for age, sex, Townsend deprivation quintile, and strategic health authority. ¶Adjusted for age, sex, and 
Townsend deprivation quintile.
Table 3: Common comorbidities newly diagnosed after Jan 1, 2009 
Incentivised practices 
(n=4645)*
Non-incentivised 
practices (n=611)*
Absolute risk diﬀ erence 
(95% CI)
Odds ratio (95% CI)† p value
(Continued from previous page)
Health action plan oﬀ ered
Prevalence 1072 (23·1%) 29 (4·8%) 18·3% (16·0–20·2%) 6·15 (1·41–26·85)|| 0·0156
Records per patient 0 (0–0) 0 (0–0) ·· ··
Secondary referral
Prevalence 3531 (76·0%) 421 (68·9%) 7·1% (3·4 to 11·1%) 1·47 (1·05–2·05)‡ 0·0256
Records per patient 2 (1–5) 1 (0–3) ·· ··
All patients assessed had complete data for 2009–11 and had received at least one health check in this period. HbA1c=glycated haemoglobin. *Data are n (%) or median (IQR). 
†Backwards elimination used in multivariate logistic regression analysis to ﬁ nd signiﬁ cant (p<0·1) covariates. ‡Adjusted for age, sex, and strategic health authority. §Adjusted 
for age and sex. ¶Adjusted for age, sex, Townsend deprivation quintile, and strategic health authority. ||Adjusted for age, sex, and Townsend deprivation quintile.
Table 2: Association between health assessments and information and practices opting into the incentivised health check scheme
Articles
www.thelancet.com/psychiatry   Vol 1   December 2014 527
terms of the proportions oﬀ ered health checks and 
baseline characteristics, including age, sex, and 
comorbidities. We hypothesised that all ID-related 
activities would be more frequent in practices opting 
into the LD-DES. All analyses were done with Stata SE 
(version 12.1). 
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
all the data in the study and had ﬁ nal responsibility for 
the decision to submit for publication. 
Results
222 incentivised practices with 8692 registered patients 
with ID, and 48 non-incentivised practices with 918 
registered patients with ID were identiﬁ ed (ﬁ gure, 
table 1). The proportions of incentivised practices diﬀ ered 
between former strategic health authorities. For example, 
10% of patients from incentivised practices were located 
in the London strategic health authority, compared with 
only 3% from non-incentivised practices. The total 
number of patients with ID in individual practices was 
the only variable signiﬁ cantly associated with opting into 
the LD-DES scheme after controlling for other practice-
level covariates (odds ratio [OR] 1·09, 95% CI 1·05–1·13, 
p<0·0001).
5256 patients with ID had complete data for 2009–11, of 
whom 4645 (88·4%) were registered with LD-DES 
incentivised practices and had received at least one health 
check during the 3-year study period (table 2). 
Incentivised practices were more likely than non-
incentivised practices to do blood tests to measure 
haemoglobin and total cholesterol concentrations in 
patients with ID. Being a patient in an incentivised 
practice was also strongly associated with being oﬀ ered 
general health status checks, speciﬁ c health assessments 
for hearing or vision, medication reviews, recorded 
health action plans, and secondary referrals (table 2).
Among newly identiﬁ ed common health conditions, 
rates of gastrointestinal and thyroid disorders, 
constipation, and being underweight or obese were 
higher for patients with ID in incentivised practices than 
in non-incentivised practices after adjustment (table 3). 
The rates of identiﬁ cation of new cases of epilepsy and 
diabetes seemed to be slightly higher in the non-
incentivised practices, but the diﬀ erences were not 
signiﬁ cant.
Read codes identifying that patients with ID had been 
invited to attend a health check were infrequently used; 
most practices only recorded completion of incentivised 
health checks. We identiﬁ ed 771 patients with codes 
indicating they had been invited to attend a health check 
(table 4), of whom 659 (85%) attended. Patients who did 
not attend health checks were more likely to be younger 
and to live in more deprived neighbourhoods than those 
who did attend, after adjustment for other covariates and 
clustering within practices (table 4).
We identiﬁ ed 2034 patients registered at incentivised 
practices who had disorders usually associated with ID 
according to our Read code list. Most of these had either 
Down’s syndrome (n=1119 [55%]) or autism (n=325 [16%]). 
1223 (60%) of the 2034 had QOF-ID codes recorded and 
Attendees 
(n=659)
Non-attendees 
(n=112)
Odds ratio (95% CI) p value
Strategic health authority
London 78 (11·8%) 21 (18·8%) 1·00 0·2888
East Midlands 29 (4·4%) 4 (3·6%) 1·64 (0·27–10·09)
East of England 67 (10·2%) 27 (4·1%) 0·80 (0·44–1·54)
West Midlands 27 (4·1%) 5 (4·5%) 1·30 (0·65–2·61)
North East 55 (8·4%) 7 (6·3%) 2·30 (0·83–6·36)
North West 145 (22·0%) 15 (13·4%) 2·71 (0·74–9·88)
Yorkshire and Humberside 0 0 ··
South Central 40 (6·1%) 9 (8·0%) 1·06 (0·22–5·22)
South East Coast 4 (0·6%) 0 N/A*
South West 214 (32·5%) 25 (22·3%) 2·52 (1·00–6·39)
Sex
Male 387 (58·7%) 68 (60·7%) 1·00 0·6501
Female 272 (41·3%) 44 (39·3%) 0·91 (0·62–1·35)
Age group (years)
18–29 143 (21·7%) 47 (42·0%) 1·00 <0·0001
30–39 118 (17·9%) 24 (21·4%) 1·43 (0·74–2·76)
40–49 158 (24·0%) 22 (19·6%) 2·06 (1·18–3·60)
50–59 145 (22·0%) 13 (11·6%) 3·46 (1·57–7·62)
60–69 70 (10·6%) 6 (5·4%) 4·88 (1·81–13·20)†
70–100 25 (3·8%) 0 ··
Townsend deprivation score quintile
1 (least) 104 (15·8%) 13 (11·6%) 1·00 0·0062
2 80 (12·4%) 16 (14·3%) 0·69 (0·31–1·50)
3 158 (24·0%) 19 (17·0%) 1·19 (0·71–1·98)
4 170 (25·8%) 40 (35·7%) 0·48 (0·25–0·92)
5 (most) 147 (22·3%) 24 (21·4%) 0·70 (0·32–1·57)
Carer type before 2009
No carer speciﬁ ed 624 (94·7%) 109 (97·3%) 1·00  0·5613
Carer (type unspeciﬁ ed) 35 (5·3%) 3 (2·7%) 1·42 (0·44–4·62)
Carer (informal) 0 0 ··
BMI (kg/m²)‡
Mean (95% CI) 28·8 (28·0–29·6) 28·2 (25·4–31·0) ·· ··
Missing data 344 (52·2%) 80 (71·4%) ··
Systolic blood pressure (mm Hg)‡
Mean (95% CI) 127·0 (126–129 127 (124–132) ·· ··
Missing data 267 (40·5%) 71 (63·4%) ··
Total cholesterol (mmol/L)‡
Mean (95% CI) 5·0 (4·8–5·1) 5·0 (4·5–5·4) ·· ··
Missing data 479 (72·7%) 100 (89·3%) ··
HbA1c (%)‡
Mean (95% CI) 7·2 (6·6–7·8) 7·7 (2·3–13·1) ·· ··
Missing data 610 (92·6%) 109 (97·3%) ··
(Table 4 continues on next page)
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were, therefore, on the practice register to be considered 
for the LD-DES, but 811 (40%) did not. No patients without 
QOF-ID codes were oﬀ ered annual ID health checks, 
irrespective of whether they were registered with 
incentivised or non-incentivised practices. Patients who 
did not have QOF-ID codes across all practices were more 
likely to be women (63·1% vs 43·1%), in the youngest age 
group (36·7% vs 28·0%), and have Townsend deprivation 
scores in quintile 1 (21·6% vs 18·4%).
Discussion
This study was a large-scale analysis of a national annual 
health check scheme based in primary care and 
speciﬁ cally targeting adults with ID, which used data 
representative of patients throughout England.20 Practices 
that had opted in to the LD-DES scheme generally had 
increased rates of general and speciﬁ c health assessments 
of their patients with ID recorded, and an increased 
likelihood of identifying new comorbidities, including 
thyroid and gastrointestinal disorders. Incentivised 
practices were also more likely than non-incentivised 
practices to oﬀ er health action plans and refer ID patients 
to secondary care. Among invited patients who did not 
attend health checks, non-attenders were younger and 
more socially deprived than attenders. 
Our study provides important evidence that health 
checks targeting adults with ID have positive eﬀ ects on 
health-service provision that can reduce the health 
inequities commonly experienced by this population.4,6 
This ﬁ nding is particularly pertinent in view of a 
conﬁ dential enquiry into premature deaths of people 
with ID in England, which found far more deaths from 
causes potentially preventable with good quality health 
care than in the general population.5 Our results suggest 
that annual health checks for people with ID could 
contribute to a reduction in the excess of avoidable 
deaths. Similar interventions have been assessed in 
Scotland13 and Australia,12,14 but the studies were small. 
An English study showed that the LD-DES scheme is 
associated with increased identiﬁ cation of disorders that 
are incentivised for the general population under the 
QOF scheme, such as diabetes.28 Our data indicated that 
epilepsy and diabetes, which are incentivised under this 
general scheme, were likely to be identiﬁ ed by practices 
in general, whereas targeted health checks for people 
with ID resulted in increased identiﬁ cation of other 
disorders, such as thyroid and gastrointestinal disorders, 
which are common and potentially problematic in the 
ID population.
Although our results provide support for the LD-DES in 
England, which is, to our knowledge, the largest such 
national scheme, longer-term eﬀ ects of the scheme on 
morbidity and mortality need to be investigated. The 
current gross inequalities in provision of and access to 
health care for the ID population make a strong case for 
the potential beneﬁ t of systematic health checks, but 
whether these increased health assessments and 
Panel: Research in context
Systematic review
We did not do a systematic review before starting this cohort study, as we were aware of 
several comprehensive reviews in this area to which we referred. Lennox and colleagues31 did a 
pooled analysis of relevant studies published between 1980 and 2009 identiﬁ ed on Medline, 
PsycINFO, Embase, and CINAHL with the search terms “intellectual disability”, “trial OR study 
OR control”, “adults”, and “short health screening or health assessment”, and identiﬁ ed two 
randomised trials and one cohort study which reported that participants who had the health 
screening received more health assessments and health promotion activities than those who 
did not. We also referred to a systematic review of health checks for people with intellectual 
disabilities (ID) that was based on searches of Medline, CINAHL, Web of Science, and PsycINFO 
for peer-reviewed quantitative research or qualitative research published between 1989 and 
2010 with terms related to “learning disabilities” and associated database-speciﬁ c synonyms, 
combined with search terms relating to the eﬀ ectiveness of annual health checks for people 
with ID. The evidence indicated that health checks are eﬀ ective to identify previously 
undetected disorders in people with ID and showed some evidence for an association 
between increased medical activity and positive eﬀ ects on health outcomes.32 We updated 
our literature search by checking the references of a 2013 publication that covered the time 
period of our study.33 These reviews highlight the variability of the provision and uptake of 
primary care health checks for people with ID, despite evidence that such checks can be 
eﬀ ective in recognising previously unrecognised important morbidities.
Interpretation
Our study contributes substantial evidence in favour of primary care health checks for 
people with ID in English primary care and provides speciﬁ c information about what 
activities are associated with incentivised health checks (increased investigations, 
general and speciﬁ c health assessments, identiﬁ cation of common comorbid disorders, 
medication reviews, and referrals to secondary care) across a large, demographically 
representative population sample. Development of the methodology for analysis of 
large datasets in this way will enable further assessment of long-term eﬀ ects of primary 
care health checks on health outcomes in the ID population and investigation of other 
factors contributing to the poor health they experience and the variable delivery and 
uptake of such checks.
Attendees 
(n=659)
Non-attendees 
(n=112)
Odds ratio (95% CI) p value
(Continued from previous page)
Comorbidity before 2009
Epilepsy 197 (29·9%) 22 (19·6%) 1·56 (0·75–3·01) 0·2573
Diabetes 42 (6·4%) 4 (3·6%) 1·11 (0·40–3·09) 0·8352
Thyroid disorder 56 (8·5%) 3 (2·7%) 2·64 (0·77–9·05) 0·1229
Gastrointestinal disorders 77 (11·7%) 3 (2·7%) 3·52 (1·44–8·61) 0·0057
Constipation 83 (12·6%) 5 (4·5%) 2·05 (0·77–5·48) 0·1509
Underweight (BMI 
<18·0 kg/m²)
52 (7·9%) 15 (13·4%) 0·82 (0·42–1·60) 0·5589
Obese (BMI >30·0 kg/m²) 203 (30·8%) 22 (19·6%) 1·37 (0·79–2·37) 0·2654
Asthma or COPD 154 (23·4%) 22 (19·6%) 1·44 (0·76–2·69) 0·2604
Hypertension 126 (19·1%) 15 (13·4%) 0·80 (0·44–1·48) 0·4771
Depression 206 (31·3%) 35 (31·3%) 1·06 (0·65–1·67) 0·8534
Baseline characteristics are shown. Data were adjusted for other covariates and clustering within practices. 
BMI=body-mass index. HbA1c=glycated haemoglobin. COPD=chronic obstructive pulmonary disease. *As data were 
available for only four patients, this strategic health authority was excluded from the analysis. †Ages 60–100 years 
were combined for this analysis. ‡Mean of all measurements in 2007 and 2008. 
Table 4: Multivariate logistic regression analysis of variables associated with attendance in patients with 
intellectual disability invited to attend health checks
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detection of comorbidities are associated with improved 
access to appropriate secondary health care and improved 
outcomes should be urgently established. Database 
studies of large populations over longer periods could 
assist in such analyses.
Factors relating to the variability between practices 
opting into such incentivisation schemes and patients 
taking up the oﬀ er of health checks need to be clariﬁ ed as 
they contribute to the underlying health inequalities in the 
ID population. Data from the English Public Health 
Observatory indicate that nationally only 52% of patients 
eligible for incentivised ID health checks currently receive 
them, with large variations between and within localities.29 
We found that even when practices opted in to the 
LD-DES, more than a third of adults with speciﬁ c 
disorders known to cause ID were excluded from health 
checks because no QOF-ID codes were recorded. All 
primary care physicians participating in the LD-DES 
should be encouraged to cross-reference individuals with 
Read codes for such speciﬁ c syndromes, for instance 
Down’s syndrome or fragile X syndrome, against QOF-ID 
codes and their LD-DES registers to ensure that all 
potentially eligible patients are included. We suggest 
making this approach a national-level criterion for 
participation in the LD-DES.
In the current climate of budgetary constraint, 
establishing the cost eﬀ ectiveness of health checks for 
people with ID would be useful. A study in Glasgow, UK, 
found that the mean cost of care for adults with ID who 
received standard care only was greater than that for 
those receiving ID health checks.30
Finally, health systems diﬀ er worldwide, and it remains 
to be established whether similar health-check schemes 
for people with ID can be usefully implemented in other 
countries.
Our research had several limitations. First, we had to 
infer which practices had opted in to the LD-DES because 
this information was not available to the THIN recording 
scheme. We based our assumption on the distribution of 
health checks. What we deﬁ ned as the incentivised 
practices might have included some practices that had not 
opted in to the scheme, and there might have been some 
in the non-incentivised group that had opted in but had 
not implemented the programme successfully. We think, 
however, that such instances are unlikely because most 
practice reimbursement is given on evidence of completed 
health checks indicated by appropriate Read codes.
Second, we assessed all the data together and did not 
investigate the quality of health checks within individual 
practices. Our data indicate that the number of patients 
recorded in the practice register as having ID was a 
signiﬁ cant practice-level factor associated with opting 
into the LD-DES. Primary care physicians in practices 
with high numbers of patients with ID are likely to be 
more experienced and conﬁ dent in working with this 
population. Provision of additional training for 
practitioners with fewer ID patients on their registers, 
or possibly a model of experienced primary care 
physicians working across several practices might be 
ways to address this potential inequity.
Third, as this was an observational study, we attempted to 
reduce bias by adjusting for known confounding. We were 
unable, however, to adjust for all confounders because we 
had to exclude those with missing data. The information in 
medical databases is generally well recorded,23 although we 
identiﬁ ed some issues with missing data. Only 5256 (55%) 
of 9610 patients had complete data for the 3-year period. 
Data might have been missing for people who did not 
attend consultations or for those who attended consultations 
where QOF-ID codes were not accurately recorded.
Our study indicates that primary care health checks for 
people with ID are associated with an increase in health-
related activities as well as the identiﬁ cation of important 
comorbidities, which might lead to a reduction in 
avoidable deaths if eﬀ ectively managed. However we 
found that 40% (811 of 2034) of patients with speciﬁ c ID 
syndromes (eg, Down’s syndrome) did not have speciﬁ c 
QOF-ID codes recorded and were therefore not oﬀ ered a 
health check. The provision and uptake of primary care 
health checks for people with ID are highly variable 
(panel) and the contributing factors need to be addressed 
if access to such checks is not to be another of the 
inequities experienced by this population. Longitudinal 
research needs to be done to assess the relation between 
primary care health checks, identiﬁ cation of serious 
comorbidities, and longer-term health outcomes in the ID 
population.  
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